Gabather AB
GABA | FN
Overview
Corporate Details
- ISIN(s):
- SE0010869552 (+1 more)
- LEI:
- 549300VLUOMD0TE1O093
- Country:
- Sweden
- Address:
- FORSKARGATAN 20 J, 151 36 Södertälje
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Gabather AB focuses on developing therapies for central nervous system disorders. Their research targets depression and cognitive impairment.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |